Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Everest Medicines Receives Taiwan TFDA Approval for NEFECON® to Treat IgA Nephropathy
Monday, October 21, 2024Everest Medicines has announced the approval of NEFECON by Taiwans Food and Drug Administration TFDA NEFECON is a patented delayedrelease oral formulation of budesonide
AFT Secures Late-Stage R&D Agreement for Novel Injectable Treatment
Monday, October 21, 2024AFT Pharmaceuticals has announced a partnership with two European companies to finalise the research and development of a novel injectable medicine containing a patented New Chemical Entity NCE
Antengene’s XPOVIO® Gains Third Approval in South Korea for Multiple Myeloma Treatment
Saturday, October 19, 2024Antengene has announced that the South Korean Ministry of Food and Drug Safety MFDS has approved a supplemental New Drug Application sNDA for XPOVIO selinexor XPOVIO works by inhibiting the nuclear export protein XPO which leads to the accumulation a...
Astellas Receives FDA Approval for VYLOY™ in Advanced Gastric and GEJ Cancer Treatment
Saturday, October 19, 2024Astellas Pharma has announced that the US Food and Drug Administration FDA has approved VYLOY zolbetuximabclzb for use in combination with fluoropyrimidine and platinumbased chemotherapy
AbbVie Receives Approval of VYALEV™ for Adults with Advanced Parkinson's Disease
Friday, October 18, 2024AbbVie has announced that the US Food and Drug Administration FDA has approved VYALEV foscarbidopa and foslevodopa the first and only subcutaneous hour continuous infusion therapy using levodopa for managing motor fluctuations in adults with advanced...
Sanofi and Orano Partner to Develop Next-Generation Radioligand Therapies
Friday, October 18, 2024Sanofi and Orano Med have entered into a strategic agreement to combine expertise in the fight against rare cancers aiming to accelerate the development of nextgeneration radioligand therapies RLTs
Viatris Enters into Agreement with Lexicon on Global Rights to Sotagliflozin Outside U.S. and Europe
Thursday, October 17, 2024Viatris has entered an exclusive licensing agreement with Lexicon Pharmaceuticals for the rights to sotagliflozin in markets outside the United States and Europe Sotagliflozin is an oral inhibitor targeting sodiumglucose cotransporter types and SGL...
Firefly Neuroscience Enters into Collaboration with Bright Minds to Analyse Data Using AI Technology
Thursday, October 17, 2024Firefly Neuroscience has announced a collaboration with Bright Minds Biosciences Inc BMB a selective HTC receptor agonist has shown strong activity in both in vitro and in vivo studies It is believed to offer a better tolerance profile compared to si...
SELLAS Granted FDA Rare Paediatric Disease Designation for Acute Myeloid Leukemia
Wednesday, October 16, 2024SELLAS Life Sciences Group has received Rare Pediatric Disease Designation RPDD from the US Food and Drug Administration FDAPaediatric acute myeloid leukaemia AML is a rare but aggressive cancer affecting childrens blood and bone marrow It disrupts n...
Alleo and Ubiquigent Partner on AI-Driven Initiative to Accelerate DUB-Targeted Drug Discovery
Wednesday, October 16, 2024Ubiquigent has announced a strategic collaboration with Alleo Labs Alleo will combine its AI capabilities with Ubiquigents expertise in DUBfocused drug discovery DUBs as the drug target to harnessing them for the modulation or stabilisation of a give...
